Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, Ireland
SEC filing record 1 source field available
Fiscal year end
31 December
Nabriva Therapeutics plc has filed 695 SEC EDGAR filings since 14 May 2015

SEC filing history

Showing 476-500 of 695 matching filings.

Per page
25
Current page
20
8-K File 001-37558

8-K

Filing date
19 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 May 2018
Reporting date
23 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 May 2018
Reporting date
23 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 May 2018
Reporting date
23 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 May 2018
Reporting date
23 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 May 2018
Reporting date
23 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
21 May 2018
Reporting date
21 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-37558

CT ORDER filing

Filing date
17 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 May 2018
Reporting date
02 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 May 2018
Reporting date
02 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 May 2018
Reporting date
02 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 May 2018
Reporting date
02 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 May 2018
Reporting date
02 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 May 2018
Reporting date
02 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-223739

EFFECT filing

Filing date
27 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
25 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-37558

CT ORDER filing

Filing date
25 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
20 Apr 2018
Reporting date
20 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

SEC SCHEDULE 13G

Filing date
10 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-223739

S-3/A

Filing date
09 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Apr 2018
Reporting date
30 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
30 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
27 Mar 2018
Reporting date
21 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .